Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Pier Paolo Maria Berton Giachetti

European Institute of Oncology

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Articles (11)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Carmine Valenza

European Institute of Oncology

ITALY

View details

Edoardo Crimini

Medical Oncologist

European Institute of Oncology

ITALY

View details

Caterina Sposetti

Dana-Farber Cancer Institute

UNITED STATES

View details

Chiara Corti

Dana-Farber Cancer Institute

UNITED STATES

View details

Giuseppe Curigliano

European Institute of Oncology

ITALY

View details

Antonio Marra

Research Associate

Sloan Kettering Institute

UNITED STATES

View details

Federica Giugliano

Institut Gustave Roussy

FRANCE

View details

Yue Zheng

Dana-Farber Cancer Institute

UNITED STATES

View details

Liliana Ascione

Dana-Farber Cancer Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pier Paolo Maria Berton Giachetti

Research Interests

Make your next move.

Explore related searches

Articles (11)

Harnessing Vaccines in the Treatment of Solid Tumors: Advances, Challenges, and Future Directions

Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor–Positive Breast Cancer: A Cohort Study

Second ipsilateral locoregional recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a cohort study

Prognostic impact of tumor-infiltrating lymphocytes in HER2+ metastatic breast cancer receiving first-line treatment

Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting

Immune-Related Adverse Event Likelihood Score Identifies "Pure" IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population.

Pyrotinib in combination with first-line trastuzumab and docetaxel for patients with HER2-positive metastatic breast cancer: a new therapeutic option?

Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors

Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study

Safety of mRNA-COVID-19 Vaccines in Patients With Thoracic Cancers

Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detection

Collaborators (9)

Carmine Valenza

Edoardo Crimini

Caterina Sposetti

Chiara Corti

Giuseppe Curigliano

Antonio Marra

Federica Giugliano

Yue Zheng

Liliana Ascione

Make your next move.